Hospital Infection Therapeutics Market Size, Share, Overview, Key Players and Opportunities 2022-2027

According to IMARC Group's latest report, titled "Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global hospital infection therapeutics market reached a value of around US$ 11 Billion in 2021. Looking forward, IMARC Group expects the global hospital infection therapeutics market to grow at a CAGR of 2.4% during 2022-2027.

Hospital infection therapeutics refers to drugs or medications used to treat diseases or infections. They can be acquired from viral, bacterial and fungal pathogens present in hospitals, nursing homes, rehabilitation centers, outpatient clinics, and other treatment centers. Therapeutics, such as antibacterial, antiviral, antifungal, and infection-based drugs, are used to prevent hospital-acquired infections (HAIs) like urinary tract infections (UTI), pneumonia, surgical site infection, and bloodstream infections (BSI).

Request for a PDF sample of this report: https://www.imarcgroup.com/hospital-infection-therapeutics-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Hospital Infection Therapeutics Market Trends:

The global hospital infection therapeutics market is primarily driven by the rising prevalence of chronic diseases that have increased hospital admissions and cases of HAIs. The growing geriatric population and rising healthcare expenditure are also escalating the demand for these therapeutics. Furthermore, there has been a development of advanced therapies, drugs, vaccines and coverings that can be used for the treatment of infections with specific symptoms. Moreover, extensive investment in research and development (R&D) activities to develop new HAI drugs, such as Zerbaxa by Merck & Co., for the treatment of ventilator-associated bacterial pneumonia (VABP), are expected to influence the market growth in the near future.

Hospital Infection Therapeutics Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global hospital infection therapeutics market has also been examined along with the profiles of the key players.

Some of these key players include:
Allergan Plc (AbbVie Inc.)
AstraZeneca Plc
Bayer Aktiengesellschaft
Bristol-Myers Squibb Company
Hoffmann-La Roche AG (Roche Holding AG)
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Pfizer Inc.
Sanofi S.A.

Key Market Segmentation:

The report has segmented the hospital infection therapeutics market based on drug type, indication, and region.

Breakup by Drug Type:
Anti-bacterial Drugs
Anti-fungal Drugs
Anti-viral Drugs
Others

Breakup by Indication:
Blood Stream Infections
Urinary Tract Infections
Surgical Site Infections
Pneumonia
Others

Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2393&flag=C

Key highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Apheresis Equipment Market: https://bit.ly/3M93n4m

RNA Interference Drug Delivery Market: https://bit.ly/3ROPjyp

Multiple Sclerosis Therapies Market: https://bit.ly/3rzqFXH

Portable Medical Ventilators Market: https://bit.ly/3EgRNCq

Nucleic Acid Labelling Market: https://bit.ly/3V4i4Kb

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.